These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4443900)

  • 21. Effects of hexamethonium and decamethonium on end-plate current parameters.
    Milne RJ; Byrne JH
    Mol Pharmacol; 1981 Mar; 19(2):276-81. PubMed ID: 6971989
    [No Abstract]   [Full Text] [Related]  

  • 22. [Curare-like activity of some new bis-quaternary compounds].
    Danilov AF; Indenbom ML; Mikhel'son MIa; Khromov-Borisov NV
    Farmakol Toksikol; 1966; 29(5):582-8. PubMed ID: 5995069
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuromuscular transmission in vivo and the actions of decamethonium: a micro-electrode study.
    Roberts DV; Thesleff S
    Acta Anaesthesiol Scand; 1965; 9(3):165-72. PubMed ID: 4220911
    [No Abstract]   [Full Text] [Related]  

  • 24. Frequency of opening of channels by depolarizing drugs [proceedings].
    Wray D
    J Physiol; 1978 Nov; 284():149P-150P. PubMed ID: 731495
    [No Abstract]   [Full Text] [Related]  

  • 25. Interaction between facilitating and depolarizing drugs at the neuromyal junction of the cat.
    Blaber LC; Karczmar AG
    J Pharmacol Exp Ther; 1967 Apr; 156(1):55-62. PubMed ID: 6023600
    [No Abstract]   [Full Text] [Related]  

  • 26. Depolarization block and phase II block at the neuromuscular junction.
    Waud DR; Waud BE
    Anesthesiology; 1975 Jul; 43(1):10-20. PubMed ID: 1147293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of cholinesterase in the neuromuscular effects of succinylcholine, decamethonium and hexafluorenium.
    Scaf AH; van den Akker J; Westenberg HG
    Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):177-92. PubMed ID: 4846189
    [No Abstract]   [Full Text] [Related]  

  • 28. Depolarizing neuromuscular block.
    Galindo A
    Anesthesiology; 1971 May; 34(5):490-1. PubMed ID: 4324391
    [No Abstract]   [Full Text] [Related]  

  • 29. [Current views on the mechanism of action of neuromuscular blocking agents].
    Foldes FF
    Acta Anaesthesiol Scand Suppl; 1966; 25():207-18. PubMed ID: 6003288
    [No Abstract]   [Full Text] [Related]  

  • 30. Neuromuscular blocking activity and other pharmacologic properties of various carnitine derivatives.
    Hosein EA; Booth SJ; Gasoi I; Kato G
    J Pharmacol Exp Ther; 1967 Jun; 156(3):565-72. PubMed ID: 6028881
    [No Abstract]   [Full Text] [Related]  

  • 31. Further studies on the neuromuscular effects of beta-diethylaminoethyl-diphenyl propylacetate hydrochloride (SKF-525-A).
    Suarez-Kurtz G; Paulo LG; Fonteles MC
    Arch Int Pharmacodyn Ther; 1969 Jan; 177(1):185-95. PubMed ID: 5353875
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of acetylcholine, decamethonium and succinylcholine on neuromuscular transmission in the rat.
    THESLEFF S
    Acta Physiol Scand; 1955 Oct; 34(4):386-92. PubMed ID: 13282745
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental study on the neuromuscular blocking action of procaine amide.
    Galzigna L; Manani G; Mammano S; Gasparetto A; Deana R
    Agressologie; 1972; 13(2):107-16. PubMed ID: 4342790
    [No Abstract]   [Full Text] [Related]  

  • 34. Activation of muscle spindles by succinylcholine and decamethonium, the effects of curare.
    GRANIT R; SKOGLUND S; THESLEFF S
    Acta Physiol Scand; 1953; 28(2-3):134-51. PubMed ID: 13079899
    [No Abstract]   [Full Text] [Related]  

  • 35. Hexafluorenium bromide: current status and a review.
    Britton RM; Figueroa M
    Anesth Analg; 1973; 52(1):100-5. PubMed ID: 4567515
    [No Abstract]   [Full Text] [Related]  

  • 36. The mode of neuromuscular block caused by acetylcholine, nicotine, decamethonium and succinylcholine.
    THESLEFT S
    Acta Physiol Scand; 1955 Oct; 34(2-3):218-31. PubMed ID: 13282730
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of anatoxin I at the neuromuscular junction.
    Biggs DF; Dryden WF
    Proc West Pharmacol Soc; 1977; 20():461-6. PubMed ID: 408823
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of neuromuscular block produced by streptomycin.
    Dunkley B; Sanghvi I; Goldstein G
    Arch Int Pharmacodyn Ther; 1973 Feb; 201(2):213-23. PubMed ID: 4353372
    [No Abstract]   [Full Text] [Related]  

  • 39. The clinical use of muscle relaxants.
    Foldes FF
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):5-24. PubMed ID: 6049585
    [No Abstract]   [Full Text] [Related]  

  • 40. Myoneural blocking effect of some monoamine oxidase inhibitors.
    Dutta SN; Pradhan SN
    Arch Int Pharmacodyn Ther; 1965 May; 155(1):188-95. PubMed ID: 5834933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.